Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
| Molecular Weight | 495.6 g/mol |
|---|---|
| Molecular Formula | C16H18Br2ClN3O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 494.93829 g/mol |
| Monoisotopic Mass | 492.94034 g/mol |
| Topological Polar Surface Area | 82 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 533 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Halofuginone Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Halofuginone Hydrobromide, including repackagers and relabelers. The FDA regulates Halofuginone Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Halofuginone Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Halofuginone Hydrobromide supplier is an individual or a company that provides Halofuginone Hydrobromide active pharmaceutical ingredient (API) or Halofuginone Hydrobromide finished formulations upon request. The Halofuginone Hydrobromide suppliers may include Halofuginone Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Halofuginone Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Halofuginone Hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Halofuginone Hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Halofuginone Hydrobromide DMFs exist exist since differing nations have different regulations, such as Halofuginone Hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Halofuginone Hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Halofuginone Hydrobromide USDMF includes data on Halofuginone Hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Halofuginone Hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Halofuginone Hydrobromide suppliers with USDMF on PharmaCompass.
Halofuginone Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Halofuginone Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Halofuginone Hydrobromide GMP manufacturer or Halofuginone Hydrobromide GMP API supplier for your needs.
A Halofuginone Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Halofuginone Hydrobromide's compliance with Halofuginone Hydrobromide specifications and serves as a tool for batch-level quality control.
Halofuginone Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Halofuginone Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Halofuginone Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Halofuginone Hydrobromide EP), Halofuginone Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Halofuginone Hydrobromide USP).
LOOKING FOR A SUPPLIER?
